Sanofi India is expecting a muted growth in the domestic market in 2017 and therefore the company will be focusing to drive the volume growth as well as exports. The focus will be to increase the domestic volume growth on one side and drive exports on the other, as the latter looks more promising.
Moreover, to shore up exports, the company is in the process of unveiling a strategic project to boost its competitiveness and productivity through operational improvement as part of a specially designed programme named ‘Fit for Future’ at both its manufacturing sites.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.